title: [Permanent catheter as an alternative vascular access for hemodialysis].
abstract: There are presented own experiences in permanent catheter application as vascular access for hemodialysis. During 1.5 year in 15 patients 18 catheters were inserted. 3 catheters had to be exchanged during first month. Catheter malfunctions (complete obstruction, ventil sign) were observed 13 times in 5-in all patients catheter patients (ratio 3.88/1000 days). Streptokinase and Urokinase were applied 9 times-in all patients catheter patency were reinstituted (however, 2 patients had insufficient blood flows). Infective complications (local or general) occurred 4 times in 3 patients (ratio 1.55/1000 days)-there were no necessity for catheter removal. On the base of own experience, as well as literature, there are discussed indications for permanent catheter application as dialysis access, practical issue in the use and complications management.
authors.affiliation: Oddziału Nefrologii i Dializoterapii Wojewódzkiego Szpitala Specjalistycznego im. L. Rydygiera w Krakowie.
authors.forename: A
authors.initials: A
authors.lastname: Miłkowski
authors.forename: A
authors.initials: A
authors.lastname: Kirker
authors.forename: O
authors.initials: O
authors.lastname: Smoleński
authors.forename: A
authors.initials: A
authors.lastname: Hartwich
authors.forename: Z
authors.initials: Z
authors.lastname: Pietkun
mesh_terms: D000328:Adult; D000368:Aged; D002408:Catheters, Indwelling / Q000009:adverse effects; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000295:instrumentation*; D013300:Streptokinase / Q000008:administration & dosage; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
chemical_list: D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator